Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
DarioHealth Corp. (DRIO) specializes in digital health solutions, primarily focusing on chronic disease management through its proprietary platform. The company differentiates itself with a strong emphasis on personalized care and data analytics, targeting markets in the U.S. and Europe, particularly in diabetes and behavioral health management.
DarioHealth generates revenue primarily through subscription fees for its digital health platform, which offers personalized health management solutions. The company leverages its proprietary technology to provide real-time data and analytics, enhancing patient engagement and outcomes. This positions DarioHealth favorably against traditional healthcare models, allowing for better scalability and lower operational costs.
Adoption rates of digital health solutions in chronic disease management
Partnerships with healthcare providers and payers
Regulatory changes affecting telehealth and digital health reimbursement
Technological advancements in health data analytics
Regulatory changes in telehealth reimbursement policies
Technological disruption from competitors offering superior digital health solutions
Emergence of new entrants in the digital health space with innovative technologies
Established healthcare companies expanding into digital health services
Negative cash flow impacting operational flexibility
High reliance on continued investment for growth without immediate revenue generation
moderate - As a healthcare technology company, DarioHealth's performance is somewhat insulated from economic downturns; however, consumer spending on health solutions can be affected by economic conditions.
Interest rates have a limited direct impact on DarioHealth, but higher rates could affect the availability of capital for growth initiatives and partnerships.
minimal - The company has a manageable debt-to-equity ratio of 0.51, indicating limited reliance on credit.
growth - Investors are likely attracted to the potential for rapid expansion in the digital health market.
high - The stock has shown significant volatility, with a 1-year return of -47.5%, indicating high sensitivity to market sentiment and operational performance.